Multidisciplinary treatment for critical limb ischemia in high age patients with end stage renal disease

2019 ◽  
Vol 11 (1) ◽  
pp. 23-27
Author(s):  
Nobuhiko Ogata ◽  
Shinsuke Haraguchi ◽  
Takaaki Isshiki ◽  
Hideki Fujihara ◽  
Yusuke Yamamoto
Keyword(s):  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Multidisciplinary Treatment ◽  
Limb Ischemia ◽  
High Age ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization

2016 ◽  
Vol 63 (4) ◽  
pp. 966-973 ◽  
Author(s):  
Alexander Meyer ◽  
Werner Lang ◽  
Matthias Borowski ◽  
Giovanni Torsello ◽  
Theodosios Bisdas ◽  
...  
Keyword(s):  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Hospital Outcomes ◽  
Stage Renal Disease ◽  
End Stage

Is endovascular revascularisation worthwhile in diabetic patients with critical limb ischemia who also have end-stage renal disease?

2010 ◽  
Vol 90 (3) ◽  
pp. e79-e81 ◽  
Author(s):  
Martín Rabellino ◽  
Javier Aragón-Sánchez ◽  
Gabriela González ◽  
Tobías Zander ◽  
Sebastián Baldi ◽  
...  
Keyword(s):  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Diabetic Patients ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Kidney Transplantation Reduces the Risk of Critical Limb Ischemia and/or Amputation Among Patients With End-stage Renal Disease on Hemodialysis

2019 ◽  
Vol 58 (6) ◽  
pp. e662
Author(s):  
Andres Galarza Tapia ◽  
Alina Velescu ◽  
Carlos Ruiz Carmona ◽  
Laura Calsina Juscafresa ◽  
Lidia Marcos Garcia ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Paramalleolar Arterial Bollinger Score in the Era of Diabetes and End-Stage Renal Disease　– Usefulness for Predicting Operative Outcome of Critical Limb Ischemia –

2016 ◽  
Vol 80 (1) ◽  
pp. 235-242 ◽  
Author(s):  
Mitsuru Matsukura ◽  
Katsuyuki Hoshina ◽  
Kunihiro Shigematsu ◽  
Tetsuro Miyata ◽  
Toshiaki Watanabe
Keyword(s):  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Operative Outcome ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals The Cost-effectiveness of Managing Non-healing Foot Wounds in Patients with Critical Limb Ischemia and End-Stage Renal Disease

2013 ◽  
Vol 58 (3) ◽  
pp. 850-851
Author(s):  
Neal R. Barshes ◽  
Panos Kougias ◽  
C. Keith Ozaki ◽  
Philip P. Goodney ◽  
Michael Belkin
Keyword(s):  
Cost Effectiveness ◽  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Cost

Surgical Revascularization in Patients with End-Stage Renal Disease: Results Using a New Paradigm in Outcomes Assessment

2007 ◽  
Vol 73 (6) ◽  
pp. 598-605
Author(s):  
Wesley B. Jones ◽  
David L. Cull ◽  
Corey A. Kalbaugh ◽  
Anna L. Cass ◽  
Spence M. Taylor
Keyword(s):  
Wound Healing ◽  
Renal Disease ◽  
Limb Salvage ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Graft Patency ◽  
Surgical Revascularization ◽  
Stage Renal Disease ◽  
End Stage

Studies evaluating the outcome of surgical revascularization (SR) for critical limb ischemia in patients who have end-stage renal disease (ESRD) have differed widely in their findings and conclusions. Differences in definitions of success are largely responsible for the varying outcomes. We developed a method of outcomes assessment that incorporates four all-inclusive end-points to define success. These include primary graft patency to the point of wound healing, postoperative survival of at least 6 months, limb salvage of at least 1 year, and maintenance of ambulatory status of at least 6 months. The purpose of this study was to use this novel method of defining success to determine the outcome of SR in patients with ESRD. From 1998 to 2004, 40 patients (52 limbs) with ESRD and tissue loss underwent SR for limb salvage. Secondary graft patency and limb salvage rates at 36 months were 54.7 per cent and 53 per cent, respectively. When considering each of the four components used to define success separately, success encouragingly ranged between 60 per cent (patent graft until wound healing) and 87.5 per cent (survival for 6 months). However, if all parameters were combined, clinical success was achieved in only 40 per cent (16/40) of patients. Coronary artery disease was the only factor found to significantly reduce success ( P = 0.04). In conclusion, using this multiparameter definition of success, which combines four rather modest outcome milestones, favorable outcome occurred in the minority of cases. This study challenges our current method of analyzing success and questions our therapeutic approach to patients with critical limb ischemia and ESRD.

Sign in / Sign up

Export Citation Format

Share Document